The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: The Neoadjuvant Therapy
Interventions: DRUG: Ribocyclib, fulvestrant, triptorelin|DRUG: Doxorubicin, cyclophosphamide, paclitaxel
Sponsor: Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary